HILZ MARK T bought HSCS
July 9, 2025 · Form 4 insider transaction
HILZ MARK T bought 56,250 shares of HeartSciences Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
Represents Restricted Stock Units (the "RSUs") granted to the Reporting Person pursuant to the approval of the compensation committee of the Issuer's board of directors. The RSUs shall vest immediately upon the earlier of (i) FDA clearance of MyoVista Device (including AI algorithm) or (ii) the MyoVista Insights platform together with first AI algorithm, subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date and subject to earlier full vesting upon a Change of Control (as defined in the EA) or such other earlier vesting acceleration conditions as provided in the EA. Each vested RSU shall be settled by delivery to the Reporting Person of one share of the Issuer's common stock on the first to occur of: (i) promptly after the applicable vesting date, (ii) the date of a Change of Control or (iii) such other earlier settlement as provided in the EA.